Bryn Mawr, PA, United States of America

H William Bosch

This inventor holds 42 USPTO granted patents and 72 published patent applications, plus 8 CIPO patents and 13 EPO patents, primarily in Nanoparticulate Formulations. Top assignees: Iceutica Pty Ltd., Elan Pharma International Limited, Alkermes Pharma Ireland Limited. Active years: 1996-2026.

USPTO Granted Patents = 42 

% Patents Active = 83.3

 

 

Average Co-Inventor Count = 3.3

ph-index = 12

Forward Citations = 1,385(Granted Patents)


Location History:

  • King of Prussia, PA (US) (2002 - 2010)
  • Philadelphia, PA (US) (2018)
  • Bryn Mawr, PA (US) (1996 - 2019)

Company Filing History:


Years Active: 1996-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Nanoparticulate Formulations
Inhalable Compositions
Bioadhesive Compositions
Corticosteroid Formulations
Drug Delivery Systems
Pharmaceutical Compositions
Dry Powder Aerosols
Gamma Radiation Sterilization
Tachykinin Receptor Antagonists
Glipizide Compositions
Microprecipitation Processes
X-Ray Contrast Compositions
42 patents (USPTO):Explore Patents

Title: H William Bosch: Innovating Pharmaceutical Formulations

Introduction

H William Bosch, based in Bryn Mawr, PA, is a prolific inventor with a remarkable portfolio of 41 patents. His work primarily focuses on innovative pharmaceutical formulations, contributing significantly to advancements in drug delivery and treatment methodologies.

Latest Patents

Among his latest patents is the formulation for Abiraterone, a nanoparticulate composition of abiraterone acetate. This formulation allows for treatment at a lower dose compared to conventional abiraterone acetate formulations, enhancing the method of treating prostate cancer by combining the composition with a glucocorticoid. Another notable patent relates to the formulation of indomethacin, detailing methods for producing particles of indomethacin through dry milling processes. This invention includes compositions comprising indomethacin, medicaments derived from it, and therapeutic methods for administering indomethacin in particulate form.

Career Highlights

H William Bosch has had an extensive career in the pharmaceutical industry, marked by his tenure at Iceutica Pty Ltd. and Elan Pharma International Limited. His innovative approach has fueled the development of essential formulations that address critical healthcare needs.

Collaborations

Throughout his career, Bosch has collaborated with notable professionals including Marck Norret and Felix Meiser. These partnerships have leveraged diverse expertise, enhancing the quality and impact of his pharmaceutical inventions.

Conclusion

H William Bosch stands out as an exemplary figure in the realm of pharmaceutical innovation. His 41 patents reflect a commitment to improving drug efficacy and patient outcomes through advanced formulations. As he continues his work, Bosch's contributions promise to influence the future of pharmaceutical sciences profoundly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…